T-cell prolymphocytic leukemia (T-PLL) is a rare form of mature leukem
ia that occurs both in adults as a sporadic disease and in younger pat
ients suffering an hereditary condition, ataxia telangiectasia (AT). T
he ATM gene, located in the 11q22-23 chromosomal region, is consistent
ly mutated in AT patients. The strong predisposition of AT patients to
develop T-PLL and the high frequency of T-cell leukemias/lymphomas ob
served in atm-deficient mice, together with the known functions of the
ATRS protein, led us to evaluate the ATM gene as a potential tumor su
ppressor gene involved in T-PLL. Paired leukemic and nonleukemic cells
were obtained from a series of 15 patients suffering sporadic T-PLLs,
allowing loss of heterozygosity (LOH) analysis. LOH of the 11q22-23 r
egion was detected in 10 of these 15 cases (67%). The minimal deleted
region was defined as an approximately 2.5 Mb interval that contained
the ATM gene. No ATM rearrangement or biallelic deletion was detected
by Southern blotting in the T-PLL series. However, in five T-PLLs with
LOH of the 11q22-23 region, Western blot analysis showed either undet
ectable (3 cases) or decreased levels (1 case) of ATM protein, whereas
ATM was present at high levels in cases without LOH, The protein trun
cation test (PTT) was then used to search for mutations in the ATM gen
e. Four mutations (1 nonsense, 2 aberrant splicings, and 1 missense) w
ere detected in patients with LOH and none in patients without LOH of
the region. The acquired character of these ATM mutations was demonstr
ated in three patients. Altogether, allelic ATM inactivations by large
deletions or mutations were found in approximately two thirds of T-PL
L. ATM is thus a tumor suppressor gene whose inactivation is a key eve
nt in the development of T-cell prolymphocytic leukemias. (C) 1998 by
The American Society of Hematology.